Immunotherapy With CD22 CAR T-cells for B-Cell Lymphoma, ALL and CLL
Clinical trial NCT04163575 · UNKNOWN
Trial details
- NCT number
- NCT04163575
- Sponsor
- Kecellitics Biotech Company Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-01
- Primary completion
- 2021-07-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.